CLASSYS (214150) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
3Q26 revenue was KRW 83.0bn, flat YoY; operating profit fell 28.2% to KRW 27.0bn and net income attributable to owners fell 81.0% to KRW 6.3bn.
Softer Korean sales, FX losses and costs of shifting LATAM and Japan to direct operations weighed on quarterly profitability; growth acceleration is targeted from 2027.
Financial highlights
9M26 revenue rose 13.3% YoY to KRW 275.7bn; gross profit increased 7.3% to KRW 202.8bn, while operating profit declined 9.4% to KRW 108.1bn.
9M26 net income attributable to owners was KRW 68.3bn, down 23.6% YoY; EBITDA was KRW 121.0bn, down 7.2%.
3Q26 gross profit was KRW 61.2bn, down 3.9% YoY; SG&A rose 31.1% to KRW 34.2bn, including acquisition-related personnel and marketing costs.
Outlook and guidance
From 2027, plans target growth through China entry, U.S./EU expansion, Korean recovery and stabilization of direct-sales operations; timing depends on regulatory approvals and market conditions.
Planned launches and approvals include China Volnewmer NMPA approval in 4Q26, U.S./EU Viclara launch in 1Q27, and Ultraformer MPT approval in 2Q27.
Direct operations in Japan are expected to be fully transitioned in 4Q26; higher gross margins are expected as newly supplied products replace pre-acquisition high-cost inventory in LATAM.
Latest events from CLASSYS
- H1 2026 revenue reached KRW 192.7B with net income of KRW 62.0B and a 49.4% payout ratio.214150
Q2 2026 - Targeting $1B revenue by 2030 through global expansion and innovative EBD solutions.214150
Jefferies Global Healthcare Conference 2026 - Strong 2023 growth in revenue and EBITDA, with global expansion and merger synergies.214150
Q2 2024 - 2023 revenue up 27% YoY, EBITDA margin 52%, and global expansion accelerated post-merger.214150
Q3 2024 - 4Q24 saw robust revenue and profit growth, with strong 2025 outlook on global expansion.214150
Q4 2024 - Strong 1Q25 growth driven by exports, consumables, and margin expansion, with positive outlook.214150
Q1 2025 - Record 2Q25 revenue and profit, with robust growth outlook for 2025.214150
Q2 2025 - 3Q25 saw strong revenue and profit growth, with robust global expansion and margin gains.214150
Q3 2025 - Record revenue and profit growth in 2025, with robust 2026 outlook and global expansion.214150
Q4 2025